VJOncology Podcast

VJOncology has assembled a panel of world-renowned experts, who offer their perspectives on the latest developments in lung cancer presented at the 19th British Thoracic Oncology Group (BTOG) Annual Conference 2021.  In this podcast, Sanjay Popat, BSc, MBBS, FRCP, PhD, The Royal Marsden NHS Foundation Trust London, UK, is joined by Samreen Ahmed, MBBS, MSc(onc), FRCP, MD, University Hospitals of L...

Treatment approaches in breast cancer are multimodal, and with the onset of novel immunotherapies and targeted agents, the therapeutic landscape of patients with advanced disease has expanded. In HER2+ disease, the treatment landscape has become saturated with novel HER2-targeting agents, bringing into question how these agents should be sequenced for maximum benefit to patients. In this podcast,...

The 2021 American Society of Clinical Oncology (ASCO) Genitourinary Cancer Symposium showcased a range of exciting clinical trial data and major milestones in prostate cancer. VJOncology has bought together a team of leading experts in prostate cancer to explore their insights on key updates from this meeting. In this exclusive podcast, Neal Shore, MD, FACS, Carolina Urologic Research Center, SC w...

The American Association for Cancer Research Annual Meeting 2021 (AACR) took place virtually this year and showcased an array across the spectrum of cancer research, from cancer biology to translational studies and trial updates. In this podcast, we hear from three leading experts in genitourinary cancer and their insights from the AACR annual meeting. Yufei Wang, PhD, Dana-Farber Cancer Institute...

VJOncology has assembled a panel of leading experts, who offer their perspectives on the latest bladder and kidney cancer data presented at the American Society of Clinical Oncology (ASCO) Genitourinary Cancer Symposium, which was held virtually in February 2021. In this podcast, Arlene Siefker-Radtke, MD, University of Texas MD Anderson Cancer Center, Houston, TX, is joined by Alison Birtle, MRCP...

Traditional treatments for lung cancer include chemotherapy, radiotherapy and surgery, however the identification of oncogenic drivers, such as EGFR, ALK and ROS1, offers the potential for novel targeted therapies and personalized approaches to lung cancer treatment. Numerous studies and trials are underway which are investigating therapies targeting oncogenes including KRAS, PD-1/PD-L1 and JAK2,...

At the 17th St. Gallen International Breast Cancer Conference 2021, leading experts gathered virtually to take part in the renowned St. Gallen International Consensus Session on the optimal treatment of early breast cancer.  In this podcast, St. Gallen Consensus Session Co-Chair Giuseppe Curigliano, MD, PhD, European Institute of Oncology & University of Milan, Milan, Italy, is joined by consensus...

Following a breast cancer diagnosis, the most immediate challenges in patient management are the determination of prognosis and identification of the most appropriate adjuvant systemic therapy, the most valid of these tests include Oncotype DX and MammaPrint. In the identification of new predictive and prognostic markers, research efforts are focusing on the clinical utility of circulating and tum...

VJOncology has assembled an international panel of leading experts in lung cancer and mesothelioma to bring you the key highlights from the IASLC World Conference on Lung Cancer (WCLC), which was held virtually in January 2021. Daniel Tan (National Cancer Centre Singapore, Singapore) is joined by Melissa Johnson (Sarah Cannon Research Institute, TN) and Dean Fennell (University Hospitals of Leices...

The virtual American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium 2021 brought together leading experts in GI cancer who updated the community on the latest data and hot topics in the field. In this podcast, Tobias Arkenau, MD, PhD, Sarah Cannon Research Institute UK, London, UK, chairs an insightful panel discussion on the some of exciting developments presented at ASCO...

The virtual San Antonio Breast Cancer Symposium (SABCS) 2020 brought together leading experts in breast cancer who updated the community on the latest data and hot topics in the field. In this podcast, Erika Hamilton, MD, Sarah Cannon Research Institute, Nashville, TN, speaks to Matteo Lambertini, MD, PhD, University of Genova, IRCCS Ospedale Policlinico San Martino, Genova, Italy and Sibylle Loib...

In December, the San Antonio Breast Cancer Symposium (SABCS) 2020 convened virtually and featured key updates in the treatment and management of breast cancer, including the latest data in immune-oncology, novel targeted therapies, and many highly anticipated trial updates.

The San Antonio Breast Cancer Symposium (SABCS) 2020 took place virtually this year and showcased recent advances in the treatment and management of breast cancer.  

Significant advances have been made in the treatment of non-small cell lung cancer (NSCLC), the most common form of lung cancer. The latest trial updates in oncogene-targeted therapy for patients with advanced ALK-positive NSCLC were presented during the European Society for Medical Oncology (ESMO) 2020 Virtual Congress.

The 16th European Association of Dermato-Oncology (EADO) meeting took place virtually this year and provided an opportunity to hear from recognized experts in the field of skin cancer. Michael Postow, of Memorial Sloan Kettering Cancer Center, Alexander van Akkooi, of Netherlands Cancer Institute, and Bettina Ryll, of the Melanoma Patient Network Europe, discuss therapies in melanoma, neoadjuvant...

The European Society for Medical Oncology (ESMO) 2020 Virtual Congress brought together leading experts in oncology who updated the community... The post The Lung Cancer Sessions: learnings from the ESMO 2020 Science Weekend appeared first on VJOncology .

The treatment of cancer continues to evolve rapidly, with expanded therapeutic options and changes to clinical practice. Additionally, the care... The post The ONS/EONS Congress Roundtable Discussion with VJOncology and OncoAlert appeared first on VJOncology .

Patients with cancer consistently demonstrate poorer post-COVID-19 infection outcomes, and as a result of the pandemic, cancer services within the... The post Prioritizing patients for breast cancer surgery during COVID-19 appeared first on VJOncology .

Using precision genotyping for identifying resistance mechanisms in advanced lung cancer can help guide treatment decisions and prolong the benefit... The post Genotyping in lung cancer and multi-cancer detection appeared first on VJOncology .

Molecular testing for lung cancer mutations plays an important role in the care of patients, by enabling quicker access to... The post Molecular testing for lung cancer in the UK appeared first on VJOncology .

The views of patients with cancer, and their survivorship, is becoming increasingly important to cancer research. This podcast not only... The post Living with and beyond cancer: a patient’s quality of life is just as important as survival appeared first on VJOncology .

Immunotherapy has the potential to treat all types of cancer, making it a highly lucrative area of research. Since the... The post Advancing immunotherapy for solid tumors appeared first on VJOncology .

This is an exciting time in the breast cancer field, with advances in the development of treatments and knowledge regarding... The post Updates in breast cancer: recent clinical trials, immunotherapy, challenges & future treatment outlook appeared first on VJOncology .

In preparation for the ESMO 2018 congress, we’ve put together a series of hot topics in oncology summing up themes... The post Hot topics in oncology: precision medicine, biomarkers & immunotherapy appeared first on VJOncology .

Over the past few years, the field of bladder cancer has seen an array of exciting clinical advancements, ranging from... The post Bladder cancer: advances in the spotlight and what these mean for therapy appeared first on VJOncology .